Is Novavax Stock A Buy On Its Covid Vaccine Launch Spree?
Published
launched its updated Covid vaccine in a myriad of countries in December, pushing NVAX stock higher. Though, notably, shares remain below their 50-day moving average. Just this month, the biotech company's protein-based shot became available in Sweden, Italy, Poland, Germany, Austria and Canada.…
#nvax #sweden #poland #austria #pfe #novavax #pfizer #xbb #eris #hv1